MVIS vs. RDVT, IMMR, NVX, PRCH, CTV, BLZE, PCYG, TGAN, ONTF, and SPOK
Should you be buying MicroVision stock or one of its competitors? The main competitors of MicroVision include Red Violet (RDVT), Immersion (IMMR), NOVONIX (NVX), Porch Group (PRCH), Innovid (CTV), Backblaze (BLZE), Park City Group (PCYG), Transphorm (TGAN), ON24 (ONTF), and Spok (SPOK). These companies are all part of the "computer and technology" sector.
Red Violet (NASDAQ:RDVT) and MicroVision (NASDAQ:MVIS) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, community ranking, media sentiment and dividends.
In the previous week, Red Violet had 1 more articles in the media than MicroVision. MarketBeat recorded 2 mentions for Red Violet and 1 mentions for MicroVision. MicroVision's average media sentiment score of 0.95 beat Red Violet's score of 0.90 indicating that Red Violet is being referred to more favorably in the media.
MicroVision received 229 more outperform votes than Red Violet when rated by MarketBeat users. Likewise, 63.99% of users gave MicroVision an outperform vote while only 62.26% of users gave Red Violet an outperform vote.
63.6% of Red Violet shares are owned by institutional investors. Comparatively, 30.9% of MicroVision shares are owned by institutional investors. 10.4% of Red Violet shares are owned by company insiders. Comparatively, 1.0% of MicroVision shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Red Violet has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500. Comparatively, MicroVision has a beta of 3.06, suggesting that its share price is 206% more volatile than the S&P 500.
Red Violet currently has a consensus target price of $25.00, indicating a potential upside of 22.25%. MicroVision has a consensus target price of $3.00, indicating a potential upside of 160.87%. Given Red Violet's higher possible upside, analysts plainly believe MicroVision is more favorable than Red Violet.
Red Violet has higher revenue and earnings than MicroVision. MicroVision is trading at a lower price-to-earnings ratio than Red Violet, indicating that it is currently the more affordable of the two stocks.
Red Violet has a net margin of 23.14% compared to Red Violet's net margin of -1,212.54%. MicroVision's return on equity of 17.94% beat Red Violet's return on equity.
Summary
Red Violet beats MicroVision on 13 of the 18 factors compared between the two stocks.
Get MicroVision News Delivered to You Automatically
Sign up to receive the latest news and ratings for MVIS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MVIS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MicroVision Competitors List
Related Companies and Tools
